Literature DB >> 29282303

Inhibition of the Deubiquitinase Usp14 Diminishes Direct MHC Class I Antigen Presentation.

Amy L Palmer1, Annemieke de Jong2, Yves Leestemaker2,3, Paul P Geurink2,3, Ruud H Wijdeven2,3, Huib Ovaa2,3, Brian P Dolan4.   

Abstract

Infected or transformed cells must present peptides derived from endogenous proteins on MHC class I molecules to be recognized and targeted for elimination by Ag-specific cytotoxic T cells. In the first step of peptide generation, proteins are degraded by the proteasome. In this study, we investigated the role of the ubiquitin-specific protease 14 (Usp14), a proteasome-associated deubiquitinase, in direct Ag presentation using a ligand-stabilized model protein expressed as a self-antigen. Chemical inhibition of Usp14 diminished direct presentation of the model antigenic peptide, and the effect was especially pronounced when presentation was restricted to the defective ribosomal product (DRiP) form of the protein. Additionally, presentation specifically from DRiP Ags was diminished by expression of a catalytically inactive form of Usp14. Usp14 inhibition did not appreciably alter protein synthesis and only partially delayed protein degradation as measured by a slight increase in the half-life of the model protein when its degradation was induced. Taken together, these data indicate that functional Usp14 enhances direct Ag presentation, preferentially of DRiP-derived peptides, suggesting that the processing of DRiPs is in some ways different from other forms of Ag.
Copyright © 2018 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29282303      PMCID: PMC5782819          DOI: 10.4049/jimmunol.1700273

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  36 in total

1.  MHC class I antigen processing distinguishes endogenous antigens based on their translation from cellular vs. viral mRNA.

Authors:  Brian P Dolan; Aditi A Sharma; James S Gibbs; Tshaka J Cunningham; Jack R Bennink; Jonathan W Yewdell
Journal:  Proc Natl Acad Sci U S A       Date:  2012-04-16       Impact factor: 11.205

Review 2.  Trimming of ubiquitin chains by proteasome-associated deubiquitinating enzymes.

Authors:  Min Jae Lee; Byung-Hoon Lee; John Hanna; Randall W King; Daniel Finley
Journal:  Mol Cell Proteomics       Date:  2010-09-07       Impact factor: 5.911

3.  Enhanced Direct Major Histocompatibility Complex Class I Self-Antigen Presentation Induced by Chlamydia Infection.

Authors:  Erik D Cram; Ryan S Simmons; Amy L Palmer; William H Hildebrand; Daniel D Rockey; Brian P Dolan
Journal:  Infect Immun       Date:  2015-11-23       Impact factor: 3.441

4.  Ubiquitin-specific protease-14 reduces cellular aggregates and protects against mutant huntingtin-induced cell degeneration: involvement of the proteasome and ER stress-activated kinase IRE1α.

Authors:  Alise Hyrskyluoto; Céline Bruelle; Sofia H Lundh; Hai Thi Do; Jenny Kivinen; Elisabeth Rappou; Sami Reijonen; Tuure Waltimo; Åsa Petersén; Dan Lindholm; Laura Korhonen
Journal:  Hum Mol Genet       Date:  2014-06-20       Impact factor: 6.150

5.  A rapid, reversible, and tunable method to regulate protein function in living cells using synthetic small molecules.

Authors:  Laura A Banaszynski; Ling-Chun Chen; Lystranne A Maynard-Smith; A G Lisa Ooi; Thomas J Wandless
Journal:  Cell       Date:  2006-09-08       Impact factor: 41.582

6.  The proteasome-associated deubiquitinating enzyme Usp14 is essential for the maintenance of synaptic ubiquitin levels and the development of neuromuscular junctions.

Authors:  Ping-Chung Chen; Lu-Ning Qin; Xiao-Ming Li; Brandon J Walters; Julie A Wilson; Lin Mei; Scott M Wilson
Journal:  J Neurosci       Date:  2009-09-02       Impact factor: 6.167

7.  Ubiquitin-based probes prepared by total synthesis to profile the activity of deubiquitinating enzymes.

Authors:  Annemieke de Jong; Remco Merkx; Ilana Berlin; Boris Rodenko; Ruud H M Wijdeven; Dris El Atmioui; Zeliha Yalçin; Craig N Robson; Jacques J Neefjes; Huib Ovaa
Journal:  Chembiochem       Date:  2012-09-25       Impact factor: 3.164

8.  Enhancement of proteasome activity by a small-molecule inhibitor of USP14.

Authors:  Byung-Hoon Lee; Min Jae Lee; Soyeon Park; Dong-Chan Oh; Suzanne Elsasser; Ping-Chung Chen; Carlos Gartner; Nevena Dimova; John Hanna; Steven P Gygi; Scott M Wilson; Randall W King; Daniel Finley
Journal:  Nature       Date:  2010-09-09       Impact factor: 49.962

9.  Ubiquitin-specific protease 14 modulates degradation of cellular prion protein.

Authors:  Takujiro Homma; Daisuke Ishibashi; Takehiro Nakagaki; Takayuki Fuse; Tsuyoshi Mori; Katsuya Satoh; Ryuichiro Atarashi; Noriyuki Nishida
Journal:  Sci Rep       Date:  2015-06-10       Impact factor: 4.379

10.  Just one position-independent lysine residue can direct MelanA into proteasomal degradation following N-terminal fusion of ubiquitin.

Authors:  Christian Setz; Melanie Friedrich; Sabine Hahn; Jan Dörrie; Niels Schaft; Gerold Schuler; Ulrich Schubert
Journal:  PLoS One       Date:  2013-02-05       Impact factor: 3.240

View more
  5 in total

1.  MLN4924 Inhibits Defective Ribosomal Product Antigen Presentation Independently of Direct NEDDylation of Protein Antigens.

Authors:  Kartikeya Vijayasimha; Amy L Leestemaker-Palmer; James S Gibbs; Jonathan W Yewdell; Brian P Dolan
Journal:  J Immunol       Date:  2022-04-15       Impact factor: 5.426

Review 2.  Targeting ubiquitin signaling for cancer immunotherapy.

Authors:  Xiaofei Zhou; Shao-Cong Sun
Journal:  Signal Transduct Target Ther       Date:  2021-01-13

3.  USP14 promotes tryptophan metabolism and immune suppression by stabilizing IDO1 in colorectal cancer.

Authors:  Dongni Shi; Xianqiu Wu; Yunting Jian; Junye Wang; Chengmei Huang; Shuang Mo; Yue Li; Fengtian Li; Chao Zhang; Dongsheng Zhang; Huizhong Zhang; Huilin Huang; Xin Chen; Y Alan Wang; Chuyong Lin; Guozhen Liu; Libing Song; Wenting Liao
Journal:  Nat Commun       Date:  2022-09-26       Impact factor: 17.694

Review 4.  Small molecules that target the ubiquitin system.

Authors:  Hai Qiu Wu; David Baker; Huib Ovaa
Journal:  Biochem Soc Trans       Date:  2020-04-29       Impact factor: 5.407

Review 5.  Advances in Proteasome Enhancement by Small Molecules.

Authors:  Dare E George; Jetze J Tepe
Journal:  Biomolecules       Date:  2021-11-30
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.